PharmaCyte Biotech Inc Watch

from SC TO-I 3 pages Notice of Withdrawal for Tender of Shares of Common Stock Pursuant to the Offer to Purchase, Dated May 11, 2023 by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of Its Common Stock at a Cash Purchase Price of $3.25 Per Share the Offer, Proration Period and Withdrawal Rights Will Expire at One (1) Minute After 11:59 P.M., New York City Time, on June 9, 2023, Unless the Offer Is Extended or Terminated (Such Date and Time, as They May Be Extended, the “Expiration Date”). 1

from SC TO-I 6 pages Offer to Purchase for Cash by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of Its Common Stock at a Cash Purchase Price of $3.25 Per Share the Offer, Proration Period and Withdrawal Rights Will Expire at One (1) Minute After 11:59 P.M., New York City Time, on June 9, 2023, Unless the Offer Is Extended or Terminated (Such Date and Time, as They May Be Extended, the “Expiration Date”)

from SC TO-I 3 pages Offer to Purchase for Cash by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of Its Common Stock at a Cash Purchase Price of $3.25 Per Share the Offer, Proration Period and Withdrawal Rights Will Expire at One (1) Minute After 11:59 P.M., New York City Time, on June 9, 2023, Unless the Offer Is Extended or Terminated (Such Date and Time, as They May Be Extended, the “Expiration Date”)

from SC TO-I 3 pages Notice of Guaranteed Delivery for Tender of Shares of Common Stock of PharmaCyte Biotech, Inc. the Offer, Proration Period and Withdrawal Rights Will Expire at One (1) Minute After 11:59 P.M., New York City Time, on June 9, 2023, Unless the Offer Is Extended or Terminated (Such Date and Time, as They May Be Extended, the “Expiration Date”)

from SC TO-I 22 pages Letter of Transmittal for Tender of Shares of Common Stock Pursuant to the Offer to Purchase, Dated May 11, 2023 by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of Its Common Stock at a Cash Purchase Price of $3.25 Per Share the Offer, Proration Period and Withdrawal Rights Will Expire at One (1) Minute After 11:59 P.M., New York City Time, on June 9, 2023, Unless the Offer Is Extended or Terminated (Such Date and Time, as They May Be Extended, the “Expiration Date”)

from SC TO-I 49 pages Offer to Purchase by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of Its Common Stock at a Cash Purchase Price of $3.25 Per Share Cusip: 71715x203

from 8-K 42 pages PharmaCyte Biotech, Inc. 2,630,385 Shares of Common Stock (Par Value $0.0001 Per Share) 899,027 Pre-Funded Warrants to Purchase Shares of Common Stock and Warrants to Purchase 3,529,412 Shares of Common Stock Underwriting Agreement